Where Will Eli Lilly Be in 5 Years?
What a difference five years can make. Just look at Eli Lilly (NYSE: LLY). In April 2020, the drugmaker stood in the shadows to some extent with companies including Johnson Johnson, , and Merck boasting larger market caps. Today, Lilly ranks as not only the biggest pharmaceutical company on the planet but also the biggest healthcare company in the world with a market cap of roughly $718 billion.
But what matters more than Lilly's accomplishments in the past is what the company could do in the future. Where will Eli Lilly be in five years?
Despite Lilly's huge success in treating diabetes and obesity, it's not the leader in those markets. That honor belongs to Novo Nordisk (NYSE: NVO), which sells the blockbuster drugs Ozempic and Wegovy for treating diabetes and obesity, respectively. However, I predict that Lilly will be the top dog in diabetes and obesity within the next five years.
Source Fool.com
Pfizer Inc. Stock
With 15 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
With a target price of 27 € there is a positive potential of 23.71% for Pfizer Inc. compared to the current price of 21.83 €.
